M&S Set to Rejoin FTSE 100 After Four-Year Hiatus
Omega Diagnostics Gp (AIM:ODX) Directorate Change
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
The legalization of cannabis in Germany could potentially inspire other European nations, including the UK, to follow in its footsteps.
After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
Major UK Retailers Name and Shamed for Not Meeting Minimum Wage Standards
A total of £7 million in fines have been imposed on over 200 companies for violations affecting 63,000 employees, including non-payment of minimum wages.
Share Talk Expected Market Updates For The Week Ahead, 24 – 28th April 2023
This week is filled with busy results announcements for London-listed companies, with big names like Barclays and NatWest, AstraZeneca and GSK, Unilever and Reckitt Benckiser, as well as US tech
Omega Diagnostics Gp (AIM:ODX) Trading update
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, provides a trading update which reflects lower than expected revenue,
Omega Diagnostics Gp (AIM:ODX) US expansion update
Maiden US Laboratory FoodPrint® installation,
Omega Diagnostics Gp (AIM:ODX) Positive WHO data received for VISITECT® CD4 test
Test shows high diagnostic accuracy (specificity and sensitivity)
Omega Diagnostics Gp (AIM:ODX) Change of preliminary results date
Change of preliminary results date and investor presentation and update to CD4 sale
Omega Diagnostics Gp (AIM:ODX) Completion of Sale of the CD4 Business
Completion of Sale of the CD4 Business
Omega Diagnostics Heads of Terms agreed for Sale of CD4 Busines
Omega Diagnostics Group PLC, (AIM: ODX). announced that it has selected a preferred bidder for its CD4 business after having made an announcement nearly two months back.